Gene therapy trial for inherited blindness halted early
NCT ID NCT03328130
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tested a gene therapy for retinitis pigmentosa, a genetic eye disease that slowly leads to blindness. The treatment involved injecting a working copy of the faulty gene under the retina. The trial was stopped early, so results are limited, but the goal was to slow or stop vision loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinique Ophtalmologique, CHU de Nantes
Nantes, 44093, France
Conditions
Explore the condition pages connected to this study.